UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott–Aldrich syndrome

Nature Medicine, 2022-01, Vol.28 (1), p.71-80

2022

Volltextzugriff (PDF)

Author Correction: Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott–Aldrich syndrome

Nature Medicine, 2022-10, Vol.28 (10), p.2217-2217

2022

Volltextzugriff (PDF)

Correction of murine Rag1 deficiency by self-inactivating lentiviral vector-mediated gene transfer

Leukemia, 2011-09, Vol.25 (9), p.1471-1483

2011

Volltextzugriff (PDF)

Translational Mini‐Review Series on Immunodeficiency: Molecular defects in common variable immunodeficiency

Clinical and experimental immunology, 2007-09, Vol.149 (3), p.401-409

2007

Volltextzugriff (PDF)

Validation of a mutated PRE sequence allowing high and sustained transgene expression while abrogating WHV-X protein synthesis: application to the gene therapy of WAS

Gene therapy, 2009-05, Vol.16 (5), p.605-619

2009

Volltextzugriff (PDF)

Lentiviral vectors targeting WASp expression to hematopoietic cells, efficiently transduce and correct cells from WAS patients

Gene therapy, 2007-03, Vol.14 (5), p.415-428

2007

Volltextzugriff (PDF)

Scale-up and manufacturing of clinical-grade self-inactivating γ-retroviral vectors by transient transfection

Gene therapy, 2012-03, Vol.19 (3), p.246-254

2012

Volltextzugriff (PDF)

Efficient gene delivery to the adult and fetal CNS using pseudotyped non-integrating lentiviral vectors

Gene therapy, 2009-04, Vol.16 (4), p.509-520

2009

Volltextzugriff (PDF)

Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1

Gene therapy, 2002-03, Vol.9 (5), p.320-326

2002

Volltextzugriff (PDF)

Long-term preservation of retinal function in the RCS rat model of retinitis pigmentosa following lentivirus-mediated gene therapy

Gene therapy, 2005-04, Vol.12 (8), p.694-701

2005

Volltextzugriff (PDF)

Neonatal dendritic cells are intrinsically biased against Th‐1 immune responses

Clinical and experimental immunology, 2002-04, Vol.128 (1), p.118-123

2002

Volltextzugriff (PDF)

Critical Variables affecting clinical-grade production of the self-inactivating gamma-retroviral vector for the treatment of X-linked severe combined immunodeficiency

Gene therapy, 2012-08, Vol.19 (8), p.872-876

2012

Volltextzugriff (PDF)

Chronic granulomatous disease

Clinical and experimental immunology, 2000-10, Vol.122 (1), p.1-9

2000

Volltextzugriff (PDF)

Ectopic retroviral expression of LMO2, but not IL2Rγ, blocks human T-cell development from CD34 + cells : implications for leukemogenesis in gene therapy

Leukemia, 2007-04, Vol.21 (4), p.754-763

2007

Volltextzugriff (PDF)

In vivo gene transfer to the mouse eye using an HIV-based lentiviral vector; efficient long-term transduction of corneal endothelium and retinal pigment epithelium

Gene therapy, 2001-11, Vol.8 (21), p.1665-1668

2001

Volltextzugriff (PDF)

Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy

Nature genetics, 2000-07, Vol.25 (3), p.306-310

2000

Volltextzugriff (PDF)

Lentiviral vectors transcriptionally targeted to hematopoietic cells by WASP gene proximal promoter sequences

Gene therapy, 2005-04, Vol.12 (8), p.715-723

2005

Volltextzugriff (PDF)

Correction of SCID-X1 using an enhancerless Vav promoter

Human gene therapy, 2011-03, Vol.22 (3), p.263-270

2011

Volltextzugriff (PDF)

Permanent partial phenotypic correction and tolerance in a mouse model of hemophilia B by stem cell gene delivery of human factor IX

Gene therapy, 2006-01, Vol.13 (2), p.117-126

2006

Volltextzugriff (PDF)

Wiskott-Aldrich syndrome protein is necessary for efficient IgG-mediated phagocytosis

Blood, 2000-05, Vol.95 (9), p.2943-2946

2000

Volltextzugriff (PDF)

Immunotherapy for neuroblastoma using syngeneic fibroblasts transfected with IL-2 and IL-12

British journal of cancer, 2007-07, Vol.97 (2), p.210-217

2007

Volltextzugriff (PDF)

Current progress on gene therapy for primary immunodeficiencies

Gene therapy, 2013-10, Vol.20 (10), p.963-969

2013

Volltextzugriff (PDF)

Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor γ chain

British journal of haematology, 1998-11, Vol.103 (2), p.335-342

1998

Volltextzugriff (PDF)

Cutting Edge: The Wiskott-Aldrich Syndrome Protein Is Required for Efficient Phagocytosis of Apoptotic Cells

The Journal of immunology (1950), 2001-04, Vol.166 (8), p.4831-4834

2001

Volltextzugriff (PDF)

Dendritic Cells: The Bare Bones of Immunity

Current biology, 2004-11, Vol.14 (22), p.R965-R967

2004

Volltextzugriff (PDF)

1 – 25 von 1.279

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.048)
Mit Volltextzugriff
(917)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(633)
Life Sciences & Biomedicine
(492)
Humans
(344)
Animals
(248)
Biological And Medical Sciences
(171)
Gene Therapy
(171)
Mice
(151)
Medicine, Research & Experimental
(134)
Research & Experimental Medicine
(134)
Medical Sciences
(123)
Biotechnology & Applied Microbiology
(119)
Genetics & Heredity
(109)
Physical Sciences
(107)
Immunology
(96)
Chemistry
(82)
Fundamental And Applied Biological Sciences. Psychology
(81)
Hematology
(79)
Genetic Therapy - Methods
(73)
Gene Expression
(72)
Mutation
(67)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott–Aldrich syndrome

Author Correction: Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott–Aldrich syndrome

Correction of murine Rag1 deficiency by self-inactivating lentiviral vector-mediated gene transfer

Translational Mini‐Review Series on Immunodeficiency: Molecular defects in common variable immunodeficiency

Validation of a mutated PRE sequence allowing high and sustained transgene expression while abrogating WHV-X protein synthesis: application to the gene therapy of WAS

Lentiviral vectors targeting WASp expression to hematopoietic cells, efficiently transduce and correct cells from WAS patients

Scale-up and manufacturing of clinical-grade self-inactivating γ-retroviral vectors by transient transfection

Efficient gene delivery to the adult and fetal CNS using pseudotyped non-integrating lentiviral vectors

Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1

Long-term preservation of retinal function in the RCS rat model of retinitis pigmentosa following lentivirus-mediated gene therapy

Neonatal dendritic cells are intrinsically biased against Th‐1 immune responses

Critical Variables affecting clinical-grade production of the self-inactivating gamma-retroviral vector for the treatment of X-linked severe combined immunodeficiency

Chronic granulomatous disease

Ectopic retroviral expression of LMO2, but not IL2Rγ, blocks human T-cell development from CD34 + cells : implications for leukemogenesis in gene therapy

In vivo gene transfer to the mouse eye using an HIV-based lentiviral vector; efficient long-term transduction of corneal endothelium and retinal pigment epithelium

Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy

Lentiviral vectors transcriptionally targeted to hematopoietic cells by WASP gene proximal promoter sequences

Correction of SCID-X1 using an enhancerless Vav promoter

Permanent partial phenotypic correction and tolerance in a mouse model of hemophilia B by stem cell gene delivery of human factor IX

Wiskott-Aldrich syndrome protein is necessary for efficient IgG-mediated phagocytosis

Immunotherapy for neuroblastoma using syngeneic fibroblasts transfected with IL-2 and IL-12

Current progress on gene therapy for primary immunodeficiencies

Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor γ chain

Cutting Edge: The Wiskott-Aldrich Syndrome Protein Is Required for Efficient Phagocytosis of Apoptotic Cells

Dendritic Cells: The Bare Bones of Immunity

Aktive Filter

Suchergebnisse filtern